Skip to main content

Pricing Index · Updated April 28, 2026

Zepbound Cost in 2026: Vials, Pens, and Compounded Options

Zepbound list price runs about $1,059/mo cash-pay. Most patients pay less through Lilly Direct vials, insurance coverage, or compounded tirzepatide. Here's the full picture.

Quick answer: Zepbound list price is about $1,059/mo. Lilly Direct vials run $349 to $699/mo by dose. With insurance covering obesity meds, copays run $25 to $150/mo. Compounded tirzepatide (same molecule, different regulatory path) runs $132 to $600/mo, median $279/mo.

1. Brand-name Zepbound pricing

Zepbound and Mounjaro share an active ingredient (tirzepatide). The difference is FDA labeling: Mounjaro is approved for type 2 diabetes, Zepbound for chronic weight management. For weight-loss-focused prescriptions, Zepbound is usually the right script.

2. Lilly Direct vial pricing by dose

Vials require self-administration with a syringe. Doses available through Lilly Direct as of April 2026:

Dose Approx. monthly cost
2.5 mg$349
5 mg$499
7.5 mg$599
10 mg$699
12.5 / 15 mgNot sold via vial

3. Compounded tirzepatide alternative

Compounded tirzepatide is the same molecule, made by 503A or 503B compounding pharmacies under personalized-prescription rules. We track 52 programs offering it, ranging $132 to $600/mo (median $279).

Cheapest compounded tirzepatide: Maximus at $132/mo. Provider profile.

Top 10 by price:

Provider $/mo
Maximus $132
GobyMeds $133
Ro $149
Helimeds $149
Embody $149
Gimme Care $163
PeterMD $165
Fifty 410 $166
Big Easy Weight Loss $168
Lavender Sky Health $175

See the full pricing index for all 52 compounded tirzepatide programs.

4. Insurance coverage paths

Zepbound has a higher chance of insurance coverage than Mounjaro for weight loss because of its FDA label for chronic weight management. To check coverage:

  1. Call your insurer and ask if your plan covers obesity medications (some don't, regardless of FDA label)
  2. Ask if Zepbound is on the formulary, and at what tier
  3. Ask if prior authorization is required (usually yes for any GLP-1)
  4. If covered, ask for the copay or coinsurance amount at your pharmacy

If uncovered, the savings card brings commercial-insurance patients to about $550/mo. Without insurance, the savings card does not apply.

5. Telehealth providers offering Zepbound

We track 2 programs that explicitly offer brand-name Zepbound:

Provider Program $/mo
SHED Brand-Name Pathway (Wegovy/Zepbound) $99
NYU Langone Weight Management Weight Management Program $450

FAQ

How much does Zepbound cost without insurance in 2026?

Zepbound's list price is about $1,059/mo cash-pay. Through Lilly Direct vials, you can pay $349 to $699/mo depending on dose. Compounded tirzepatide (same molecule) runs $132 to $600/mo across 52 providers we track.

Is Zepbound covered by insurance?

More likely than Mounjaro for weight-loss prescriptions. Zepbound is FDA-approved for chronic weight management (BMI 30+, or 27+ with comorbidities). Plans with obesity-medication benefits often cover it. Without obesity benefits, it is usually denied.

What is the difference between Zepbound and Mounjaro?

Same active drug (tirzepatide), same manufacturer (Eli Lilly). Different FDA labels: Mounjaro for type 2 diabetes, Zepbound for chronic weight management. Same dose strengths (2.5 to 15 mg). For weight loss, Zepbound is usually the right prescription.

Can I switch from Zepbound to compounded tirzepatide?

Possible, but check the regulatory rules in your state. The FDA shortage ended in October 2024. Compounded tirzepatide remains legal under personalized-prescription doctrines, but enforcement is tighter than during the shortage. Your prescriber and the compounding pharmacy must comply with state-board rules.

How does the Lilly Direct Zepbound vial program work?

Self-pay program from Eli Lilly. You order single-dose vials directly from lilly.com/direct. As of April 2026, pricing is approximately $349/mo for the 2.5 mg vial, $499/mo for 5 mg, $599/mo for 7.5 mg, and $699/mo for 10 mg. Higher doses (12.5, 15 mg) are not sold via vials.


Sources

Related

Compare GLP-1 Providers →